MD Anderson Cancer Center The University of Texas — Houston, Texas

MD Anderson Cancer Center The University of Texas is a clinical research site located in Houston, Texas, United States 70030-4009.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center The University of Texas has participated in 8 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia, Primary Myelofibrosis, Post-Polycythemia Vera.

Sponsors: Amphivena Therapeutics, Inc., Sierra Oncology LLC - a GSK company, Celgene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Houston

Browse all research sites in Texas · View every site in Houston

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center The University of Texas?

MD Anderson Cancer Center The University of Texas has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center The University of Texas conducted?

MD Anderson Cancer Center The University of Texas has 8 clinical trials on record. Their work covers Acute Myeloid Leukemia, Primary Myelofibrosis, Post-Polycythemia Vera.

Is MD Anderson Cancer Center The University of Texas accredited by Crixeo Clinical Trials?

MD Anderson Cancer Center The University of Texas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center The University of Texas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.